LaGray Chemical Company to start API production

LaGray Chemical Company of Nsawam and Anuh Pharma of Mumbai, India have signed a two year collaborative agreement for the manufacture of certain active pharmaceutical ingredients in Ghana.

In the agreement, which was signed at Nsawam last week, Anuh Pharma will transfer to LaGray, technology for the manufacture of active pharmaceutical ingredients used in making essential anti-infective drugs.
The collaboration will enable LaGray to quickly manufacture anti-infectives for treating respiratory tract infections and opportunistic infections in HIV/AIDS patients.

“The acquisition of Anuh Pharma’s technology hoes a long way in enhancing our expertise and will help us to accelerate our mission to help make Ghana and West Africa self-sufficient in drug manufacturing”, said Dr. Paul Lartey, president and Chief Executive Officer of LaGray.

“We could not have asked for a better partner than Anuh Pharma, a company with decades of experience and success in active pharmaceutical ingredient manufacturing and a genuine interest in helping us to achieve our goals.” He added.

“We are very pleased to share our experience and expertise with a dynamic company like LaGray. It is making history in drug manufacturing in Africa”, said Mr. Bipin Shah, Managing Director of Anuh Pharma.

Also present at the signing ceremony were Dr. Alexandra Graham, Vice Persident and Chief Operating Officer of LaGray, Mr. Ted Bernasko, a member of the company’s Board of Directors and Mr. Umesh Shah of Pradipkumar Pharma, a sister company of Anuh Pharma.

LaGray Chemical Company is the first manufacturer of active pharmaceutical ingredients in West Africa. The company’s state of the art facility is located at Nsawam opposite the old GIHOC cannery.

IT is the first fully integrated pharmaceutical manufacturing plant in West Africa, with technology for the manufacture of both active pharmaceutical ingredients and finished dosage forms.

Anuh Pharma is a 75 year old Indian pharmaceutical company with expertise in the manufacture of active pharmaceutical ingredients. The range of services includes technology transfer and consulting.
 

For more information please contact: